This informative and educational HIV pharmacology resource is valuable for healthcare professionals, scientific researchers or anyone with an interest in HIV therapy. You can find reports on recent news and hot topics in HIV pharmacology, discover comprehensive information and advice on drug interactions, read reports from meetings and conferences, and much more!

LATEST NEWS

Review - Interactions with new and investigationals antiretrovirals.

Drug Interactions - Ginkgo and efavirenz.

Case Reports - Development of resistant TB with rifabutin and boosted protease inhibitors.

Case Reports - Etravirine-Raltegravir interaction.

Drug Interactions - Correspondence on interactions with rifampicin.

Review - Darunavir

Click here for previous news items

SITE NEWS

New drugs added to interaction charts
Added: Monday 30th March 2009
There are several additions to the interactions charts – both new drugs and a new class.

As well as introducing new drugs to existing classes, we have introduced a new class of drugs – Heart Failure Agents – which includes ACE inhibitors, angiotensin II receptor antagonists and diuretics.

DRUG INTERACTION ALERT: SWINE FLU

Potential interactions between antiviral treatment for swine flu (H1N1) and anti-HIV therapy. (Updated 13 May)

Drug interactions between anti-HIV drugs and oseltamivir (Tamiflu^®) and zanamivir (Relenza^®) have not been described to date. Based on their routes of metabolism and clearance, we have produced a chart of predicted interactions between all the influenza antivirals and anti-HIV drugs. The H1N1 virus is sensitive to the neuraminidase inhibitors oseltamivir and zanamivir, but not to the M2 proton channel inhibitors amantadine and rimantadine.
The interactions have been added to web and PDA version of the Charts. These interactions as well as notes on the pharmacological profiles of the influenza antivirals have been summarised in an updated Chart (pdf format).
A summary of prescribing guidance for the treatment and prophylaxis of influenza-like illness is available from the UK Health Protection Agency.

DRUG INTERACTION CHARTS

Access a wealth of information on HIV drug interactions by visiting our drug interactions page.

The dynamically driven process allows you to build your own customised drug interaction chart, giving detailed information on predicted interactions of specified multiple drug combinations.

HIV-CHARTS2GO

Updated May 2009.
HIV-Charts2Go, drug interaction charts for PDAs, now include interactions with etravirine, maraviroc, and raltegravir.
Registration is required to access and download HIV-Charts2Go. Registration is free and you do not need to re-register if you used the old version of HIV-Charts2Go.

Click here to login and download.

ASSOCIATED SITES

New portal providing healthcare professionals with emerging data, clinical updates, meeting reviews and latest news for HIV Drug Therapies.

A new comprehensive resource for healthcare professionals and scientists who are interested in the expanding field of HIV pharmacogenomics.

EMAIL UPDATES

Click here to register for the latest site updates via email.

Keep up-to-date with all the latest developments in HIV clinical pharmacology by registering for our regular email update service.

Last reviewed: 7 April 2009